تصفح Pharmacy Research حسب المؤلف "Tanwer P."
-
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma
Saraswati S.; Alhaider A.; Abdelgadir A.M.; Tanwer P.; Korashy H.M. ( BioMed Central Ltd. , 2019 , Article)Background: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Phloretin (PH) possesses anticancer, antitumor, and hepatoprotective effects, however, the effects and potential mechanisms of phloretin ...